Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid Tumors

NCT05902520 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

HNSCC
Melanoma
Gynecologic Cancer
Colorectal Cancer
Lung Cancer
Urogenital Cancer

Interventions

BIOLOGICAL: DP CD8 TIL
BIOLOGICAL: DP CD8 TIL KD
BIOLOGICAL: Low dose IL-2

Sponsor

AgonOx, Inc.

Collaborators

[object Object]
[object Object]